Global Post herpetic Neuralgia Treatment Market Size, Status and Forecast 2022

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.

North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.

In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.

Market Analysis and Insights: Global Post herpetic Neuralgia Treatment Market

The global Post herpetic Neuralgia Treatment market size is projected to reach US$ 2002.2 million by 2027, from US$ 1507 million in 2020, at a CAGR of 4.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post herpetic Neuralgia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post herpetic Neuralgia Treatment market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post herpetic Neuralgia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post herpetic Neuralgia Treatment market.

Global Post herpetic Neuralgia Treatment Scope and Market Size

Post herpetic Neuralgia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Post herpetic Neuralgia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel in terms of revenue and forecast for the period 2016-2027.

Anticonvulsants

Skin Patch

Other

Segment by Distribution Channel

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Pfizer

Arbor Pharma

Assertio Therapeutics

Endo Pharma

Teikoku Pharma

Teva

Mylan

Hengrui Medicine

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Anticonvulsants

1.2.3 Skin Patch

1.2.4 Other

1.3 Market by Application

1.3.1 Global Post herpetic Neuralgia Treatment Market Share by Distribution Channel: 2016 VS 2021 VS 2027

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies

1.4 Study Objectives

1.5 Years Considered

2.1 Global Post herpetic Neuralgia Treatment Market Perspective (2016-2027)

2.2 Post herpetic Neuralgia Treatment Growth Trends by Regions

2.2.1 Post herpetic Neuralgia Treatment Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Post herpetic Neuralgia Treatment Historic Market Share by Regions (2016-2021)

2.2.3 Post herpetic Neuralgia Treatment Forecasted Market Size by Regions (2022-2027)

2.3 Post herpetic Neuralgia Treatment Industry Dynamic

2.3.1 Post herpetic Neuralgia Treatment Market Trends

2.3.2 Post herpetic Neuralgia Treatment Market Drivers

2.3.3 Post herpetic Neuralgia Treatment Market Challenges

2.3.4 Post herpetic Neuralgia Treatment Market Restraints

3.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue

3.1.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue (2016-2021)

3.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Players (2016-2021)

3.2 Global Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Post herpetic Neuralgia Treatment Revenue

3.4 Global Post herpetic Neuralgia Treatment Market Concentration Ratio

3.4.1 Global Post herpetic Neuralgia Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Post herpetic Neuralgia Treatment Revenue in 2020

3.5 Post herpetic Neuralgia Treatment Key Players Head office and Area Served

3.6 Key Players Post herpetic Neuralgia Treatment Product Solution and Service

3.7 Date of Enter into Post herpetic Neuralgia Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Type (2016-2021)

4.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2022-2027)

5.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Distribution Channel (2016-2021)

5.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2022-2027)

6.1 North America Post herpetic Neuralgia Treatment Market Size (2016-2027)

6.2 North America Post herpetic Neuralgia Treatment Market Size by Type

6.2.1 North America Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)

6.2.2 North America Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)

6.2.3 North America Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)

6.3 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel

6.3.1 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)

6.3.2 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)

6.3.3 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)

6.4 North America Post herpetic Neuralgia Treatment Market Size by Country

6.4.1 North America Post herpetic Neuralgia Treatment Market Size by Country (2016-2021)

6.4.2 North America Post herpetic Neuralgia Treatment Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Post herpetic Neuralgia Treatment Market Size (2016-2027)

7.2 Europe Post herpetic Neuralgia Treatment Market Size by Type

7.2.1 Europe Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)

7.2.2 Europe Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)

7.2.3 Europe Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)

7.3 Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel

7.3.1 Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)

7.3.2 Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)

7.3.3 Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)

7.4 Europe Post herpetic Neuralgia Treatment Market Size by Country

7.4.1 Europe Post herpetic Neuralgia Treatment Market Size by Country (2016-2021)

7.4.2 Europe Post herpetic Neuralgia Treatment Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size (2016-2027)

8.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type

8.2.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)

8.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel

8.3.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)

8.3.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)

8.3.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)

8.4 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region

8.4.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Post herpetic Neuralgia Treatment Market Size (2016-2027)

9.2 Latin America Post herpetic Neuralgia Treatment Market Size by Type

9.2.1 Latin America Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)

9.2.2 Latin America Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)

9.2.3 Latin America Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)

9.3 Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel

9.3.1 Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)

9.3.2 Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)

9.3.3 Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)

9.4 Latin America Post herpetic Neuralgia Treatment Market Size by Country

9.4.1 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2016-2021)

9.4.2 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size (2016-2027)

10.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type

10.2.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)

10.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel

10.3.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)

10.3.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)

10.3.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)

10.4 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country

10.4.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Post herpetic Neuralgia Treatment Introduction

11.1.4 Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)

11.1.5 Pfizer Recent Development

11.2 Arbor Pharma

11.2.1 Arbor Pharma Company Details

11.2.2 Arbor Pharma Business Overview

11.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Introduction

11.2.4 Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)

11.2.5 Arbor Pharma Recent Development

11.3 Assertio Therapeutics

11.3.1 Assertio Therapeutics Company Details

11.3.2 Assertio Therapeutics Business Overview

11.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Introduction

11.3.4 Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)

11.3.5 Assertio Therapeutics Recent Development

11.4 Endo Pharma

11.4.1 Endo Pharma Company Details

11.4.2 Endo Pharma Business Overview

11.4.3 Endo Pharma Post herpetic Neuralgia Treatment Introduction

11.4.4 Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)

11.4.5 Endo Pharma Recent Development

11.5 Teikoku Pharma

11.5.1 Teikoku Pharma Company Details

11.5.2 Teikoku Pharma Business Overview

11.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Introduction

11.5.4 Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)

11.5.5 Teikoku Pharma Recent Development

11.6 Teva

11.6.1 Teva Company Details

11.6.2 Teva Business Overview

11.6.3 Teva Post herpetic Neuralgia Treatment Introduction

11.6.4 Teva Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)

11.6.5 Teva Recent Development

11.7 Mylan

11.7.1 Mylan Company Details

11.7.2 Mylan Business Overview

11.7.3 Mylan Post herpetic Neuralgia Treatment Introduction

11.7.4 Mylan Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)

11.7.5 Mylan Recent Development

11.8 Hengrui Medicine

11.8.1 Hengrui Medicine Company Details

11.8.2 Hengrui Medicine Business Overview

11.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Introduction

11.8.4 Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)

11.8.5 Hengrui Medicine Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Anticonvulsants

    Table 3. Key Players of Skin Patch

    Table 4. Key Players of Other

    Table 5. Global Post herpetic Neuralgia Treatment Market Size Growth by Distribution Channel (US$ Million): 2016 VS 2021 VS 2027

    Table 6. Global Post herpetic Neuralgia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 7. Global Post herpetic Neuralgia Treatment Market Size by Regions (2016-2021) & (US$ Million)

    Table 8. Global Post herpetic Neuralgia Treatment Market Share by Regions (2016-2021)

    Table 9. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 10. Global Post herpetic Neuralgia Treatment Market Share by Regions (2022-2027)

    Table 11. Post herpetic Neuralgia Treatment Market Trends

    Table 12. Post herpetic Neuralgia Treatment Market Drivers

    Table 13. Post herpetic Neuralgia Treatment Market Challenges

    Table 14. Post herpetic Neuralgia Treatment Market Restraints

    Table 15. Global Post herpetic Neuralgia Treatment Revenue by Players (2016-2021) & (US$ Million)

    Table 16. Global Post herpetic Neuralgia Treatment Market Share by Players (2016-2021)

    Table 17. Global Top Post herpetic Neuralgia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post herpetic Neuralgia Treatment as of 2020)

    Table 18. Ranking of Global Top Post herpetic Neuralgia Treatment Companies by Revenue (US$ Million) in 2020

    Table 19. Global 5 Largest Players Market Share by Post herpetic Neuralgia Treatment Revenue (CR5 and HHI) & (2016-2021)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Post herpetic Neuralgia Treatment Product Solution and Service

    Table 22. Date of Enter into Post herpetic Neuralgia Treatment Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Post herpetic Neuralgia Treatment Market Size by Type (2016-2021) (US$ Million)

    Table 25. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2016-2021)

    Table 26. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 27. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 28. Global Post herpetic Neuralgia Treatment Market Size Share by Distribution Channel (2016-2021) & (US$ Million)

    Table 29. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2016-2021)

    Table 30. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2022-2027) (US$ Million)

    Table 31. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2022-2027) & (US$ Million)

    Table 32. North America Post herpetic Neuralgia Treatment Market Size by Type (2016-2021) (US$ Million)

    Table 33. North America Post herpetic Neuralgia Treatment Market Size by Type (2022-2027) & (US$ Million)

    Table 34. North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)

    Table 35. North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)

    Table 36. North America Post herpetic Neuralgia Treatment Market Size by Country (2016-2021) & (US$ Million)

    Table 37. North America Post herpetic Neuralgia Treatment Market Size by Country (2022-2027) & (US$ Million)

    Table 38. Europe Post herpetic Neuralgia Treatment Market Size by Type (2016-2021) (US$ Million)

    Table 39. Europe Post herpetic Neuralgia Treatment Market Size by Type (2022-2027) & (US$ Million)

    Table 40. Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)

    Table 41. Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)

    Table 42. Europe Post herpetic Neuralgia Treatment Market Size by Country (2016-2021) & (US$ Million)

    Table 43. Europe Post herpetic Neuralgia Treatment Market Size by Country (2022-2027) & (US$ Million)

    Table 44. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type (2016-2021) (US$ Million)

    Table 45. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type (2022-2027) & (US$ Million)

    Table 46. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)

    Table 47. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)

    Table 48. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2016-2021) & (US$ Million)

    Table 49. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2022-2027) & (US$ Million)

    Table 50. Latin America Post herpetic Neuralgia Treatment Market Size by Type (2016-2021) (US$ Million)

    Table 51. Latin America Post herpetic Neuralgia Treatment Market Size by Type (2022-2027) & (US$ Million)

    Table 52. Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)

    Table 53. Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)

    Table 54. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2016-2021) & (US$ Million)

    Table 55. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2022-2027) & (US$ Million)

    Table 56. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2016-2021) (US$ Million)

    Table 57. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2022-2027) & (US$ Million)

    Table 58. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)

    Table 59. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)

    Table 60. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2016-2021) & (US$ Million)

    Table 61. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2022-2027) & (US$ Million)

    Table 62. Pfizer Company Details

    Table 63. Pfizer Business Overview

    Table 64. Pfizer Post herpetic Neuralgia Treatment Product

    Table 65. Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2016-2021) & (US$ Million)

    Table 66. Pfizer Recent Development

    Table 67. Arbor Pharma Company Details

    Table 68. Arbor Pharma Business Overview

    Table 69. Arbor Pharma Post herpetic Neuralgia Treatment Product

    Table 70. Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021) & (US$ Million)

    Table 71. Arbor Pharma Recent Development

    Table 72. Assertio Therapeutics Company Details

    Table 73. Assertio Therapeutics Business Overview

    Table 74. Assertio Therapeutics Post herpetic Neuralgia Treatment Product

    Table 75. Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2016-2021) & (US$ Million)

    Table 76. Assertio Therapeutics Recent Development

    Table 77. Endo Pharma Company Details

    Table 78. Endo Pharma Business Overview

    Table 79. Endo Pharma Post herpetic Neuralgia Treatment Product

    Table 80. Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021) & (US$ Million)

    Table 81. Endo Pharma Recent Development

    Table 82. Teikoku Pharma Company Details

    Table 83. Teikoku Pharma Business Overview

    Table 84. Teikoku Pharma Post herpetic Neuralgia Treatment Product

    Table 85. Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021) & (US$ Million)

    Table 86. Teikoku Pharma Recent Development

    Table 87. Teva Company Details

    Table 88. Teva Business Overview

    Table 89. Teva Post herpetic Neuralgia Treatment Product

    Table 90. Teva Revenue in Post herpetic Neuralgia Treatment Business (2016-2021) & (US$ Million)

    Table 91. Teva Recent Development

    Table 92. Mylan Company Details

    Table 93. Mylan Business Overview

    Table 94. Mylan Post herpetic Neuralgia Treatment Product

    Table 95. Mylan Revenue in Post herpetic Neuralgia Treatment Business (2016-2021) & (US$ Million)

    Table 96. Mylan Recent Development

    Table 97. Hengrui Medicine Company Details

    Table 98. Hengrui Medicine Business Overview

    Table 99. Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2016-2021) & (US$ Million)

    Table 100. Hengrui Medicine Recent Development

    Table 101. Research Programs/Design for This Report

    Table 102. Key Data Information from Secondary Sources

    Table 103. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Post herpetic Neuralgia Treatment Market Share by Type: 2020 VS 2027

    Figure 2. Anticonvulsants Features

    Figure 3. Skin Patch Features

    Figure 4. Other Features

    Figure 5. Global Post herpetic Neuralgia Treatment Market Share by Distribution Channel: 2020 VS 2027

    Figure 6. Hospital Pharmacies Case Studies

    Figure 7. Online Pharmacies Case Studies

    Figure 8. Retail Pharmacies Case Studies

    Figure 9. Post herpetic Neuralgia Treatment Report Years Considered

    Figure 10. Global Post herpetic Neuralgia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 11. Global Post herpetic Neuralgia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 12. Global Post herpetic Neuralgia Treatment Market Share by Regions: 2020 VS 2027

    Figure 13. Global Post herpetic Neuralgia Treatment Market Share by Regions (2022-2027)

    Figure 14. Global Post herpetic Neuralgia Treatment Market Share by Players in 2020

    Figure 15. Global Top Post herpetic Neuralgia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post herpetic Neuralgia Treatment as of 2020

    Figure 16. The Top 10 and 5 Players Market Share by Post herpetic Neuralgia Treatment Revenue in 2020

    Figure 17. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2016-2021)

    Figure 18. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2022-2027)

    Figure 19. North America Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 20. North America Post herpetic Neuralgia Treatment Market Share by Type (2016-2027)

    Figure 21. North America Post herpetic Neuralgia Treatment Market Share by Distribution Channel (2016-2027)

    Figure 22. North America Post herpetic Neuralgia Treatment Market Share by Country (2016-2027)

    Figure 23. United States Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 24. Canada Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 25. Europe Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 26. Europe Post herpetic Neuralgia Treatment Market Share by Type (2016-2027)

    Figure 27. Europe Post herpetic Neuralgia Treatment Market Share by Distribution Channel (2016-2027)

    Figure 28. Europe Post herpetic Neuralgia Treatment Market Share by Country (2016-2027)

    Figure 29. Germany Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 30. France Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. U.K. Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. Italy Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. Russia Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 34. Nordic Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 35. Asia-Pacific Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 36. Asia-Pacific Post herpetic Neuralgia Treatment Market Share by Type (2016-2027)

    Figure 37. Asia-Pacific Post herpetic Neuralgia Treatment Market Share by Distribution Channel (2016-2027)

    Figure 38. Asia-Pacific Post herpetic Neuralgia Treatment Market Share by Region (2016-2027)

    Figure 39. China Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. Japan Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. South Korea Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. Southeast Asia Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. India Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 44. Australia Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 45. Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 46. Latin America Post herpetic Neuralgia Treatment Market Share by Type (2016-2027)

    Figure 47. Latin America Post herpetic Neuralgia Treatment Market Share by Distribution Channel (2016-2027)

    Figure 48. Latin America Post herpetic Neuralgia Treatment Market Share by Country (2016-2027)

    Figure 49. Mexico Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 50. Brazil Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 51. Middle East & Africa Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 52. Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Type (2016-2027)

    Figure 53. Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Distribution Channel (2016-2027)

    Figure 54. Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Country (2016-2027)

    Figure 55. Turkey Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 56. Saudi Arabia Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 57. UAE Post herpetic Neuralgia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 58. Pfizer Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2016-2021)

    Figure 59. Arbor Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2016-2021)

    Figure 60. Assertio Therapeutics Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2016-2021)

    Figure 61. Endo Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2016-2021)

    Figure 62. Teikoku Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2016-2021)

    Figure 63. Teva Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2016-2021)

    Figure 64. Mylan Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2016-2021)

    Figure 65. Hengrui Medicine Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2016-2021)

    Figure 66. Bottom-up and Top-down Approaches for This Report

    Figure 67. Data Triangulation

    Figure 68. Key Executives Interviewed